BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 23460365)

  • 1. Massive aortic regurgitation following paravalvular balloon valvuloplasty of an Edwards SAPIEN valve treated by emergent CoreValve implantation: never cross a transcatheter aortic valve without a pigtail.
    Noble S; Cikirikcioglu M; Roffi M
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E609-12. PubMed ID: 23460365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Device success and 30-day clinical outcome in patients undergoing preimplant valvuloplasty in transfemoral versus omitting valvuloplasty in transapical transcatheter aortic valve replacement.
    Wong SC; Pawar S; Minutello RM; Horn EM; Skubas NJ; Devereux RB; Salemi A
    J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1111-7. PubMed ID: 26277463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcatheter aortic valve-in-valve implantation of a CoreValve in a degenerated stenotic Sapien heart valve prosthesis.
    Hoffmann R; Möllmann H; Lotfi S
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):E922-5. PubMed ID: 22707435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of paravalvular regurgitation after Edwards SAPIEN transcatheter aortic valve replacement: management of paravalvular regurgitation after TAVR.
    Martinez CA; Singh V; O'Neill BP; Alfonso CE; Bilsker MS; Martinez Clark P; Williams D; Cohen MG; Heldman AW; O'Neill WW
    Catheter Cardiovasc Interv; 2013 Aug; 82(2):300-11. PubMed ID: 23580318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement.
    Bocksch W; Grossmann B; Geisler T; Steeg M; Droppa M; Jorbenadze R; Haap M; Gawaz M; Fateh-Moghadam S
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):466-75. PubMed ID: 27184353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparatory balloon aortic valvuloplasty during transcatheter aortic valve implantation for improved valve sizing.
    Patsalis PC; Al-Rashid F; Neumann T; Plicht B; Hildebrandt HA; Wendt D; Thielmann M; Jakob HG; Heusch G; Erbel R; Kahlert P
    JACC Cardiovasc Interv; 2013 Sep; 6(9):965-71. PubMed ID: 24050862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility and safety of transfemoral implantation of Edwards SAPIEN XT prosthesis without balloon valvuloplasty in severe stenosis of native aortic valve.
    García E; Martín P; Hernández R; Rodríguez V; Fernández A; Gama V; Almería C; Macaya C
    Catheter Cardiovasc Interv; 2014 Apr; 83(5):791-5. PubMed ID: 24285561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfemoral valve-in-valve implantation for degenerated bioprosthetic aortic valves using the new balloon-expandable Edwards Sapien 3 valve.
    Gonska B; Seeger J; Rodewald C; Scharnbeck D; Rottbauer W; Wöhrle J
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):636-643. PubMed ID: 27142354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-in-human valve-in-valve implantation of a 20 mm balloon expandable transcatheter heart valve.
    Binder RK; Wood D; Webb JG; Cheung A
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):E929-31. PubMed ID: 22821872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries.
    Ihlberg L; Nissen H; Nielsen NE; Rück A; Busund R; Klaarborg KE; Soendergaard L; Harnek J; Miettinen H; Eskola M; Wahba A; Laine M
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1047-54; discussion 1054. PubMed ID: 23998786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transseptal approach for the management of paravalvular regurgitation after transcatheter aortic valve replacement.
    Martinez CA; O'Neill B; Singh V; O'Neill WW
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E587-91. PubMed ID: 23008182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes with post-dilation following transcatheter aortic valve replacement: the PARTNER I trial (placement of aortic transcatheter valve).
    Hahn RT; Pibarot P; Webb J; Rodes-Cabau J; Herrmann HC; Williams M; Makkar R; Szeto WY; Main ML; Thourani VH; Tuzcu EM; Kapadia S; Akin J; McAndrew T; Xu K; Leon MB; Kodali SK
    JACC Cardiovasc Interv; 2014 Jul; 7(7):781-9. PubMed ID: 25060022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prosthesis-Specific Predictors of Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement: Impact of Calcification and Sizing on Balloon-Expandable versus Self-Expandable Transcatheter Heart Valves.
    Stähli BE; Nguyen-Kim TD; Gebhard C; Erhart L; Frauenfelder T; Tanner FC; Falk V; Landmesser U; Nietlispach F; Lüscher TF; Maier W; Binder RK
    J Heart Valve Dis; 2015 Jan; 24(1):10-21. PubMed ID: 26182615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter aortic valve implantation: anesthetic considerations.
    Billings FT; Kodali SK; Shanewise JS
    Anesth Analg; 2009 May; 108(5):1453-62. PubMed ID: 19372319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcatheter aortic valve implantation for treatment of patients with degenerated aortic bioprostheses--valve-in-valve technique.
    Gotzmann M; Mügge A; Bojara W
    Catheter Cardiovasc Interv; 2010 Dec; 76(7):1000-6. PubMed ID: 20824744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe intraprosthetic regurgitation and valve embolization after transcatheter aortic valve implantation.
    Ben-Dor I; Satler LF; Pichard AD; Waksman R
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):392-6. PubMed ID: 22566389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfemoral implantation of Edwards Sapien XT aortic valve without previous valvuloplasty: role of 2D/3D transesophageal echocardiography.
    García E; Almería C; Unzué L; Jiménez-Quevedo P; Cuadrado A; Macaya C
    Catheter Cardiovasc Interv; 2014 Nov; 84(6):868-76. PubMed ID: 24482054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High pacing rates for management of aortic insufficiency after balloon aortic valvuloplasty or transcatheter aortic valve replacement.
    Ali O; Salinger MH; Levisay JP; Feldman T
    Catheter Cardiovasc Interv; 2014 Jan; 83(1):162-8. PubMed ID: 23441087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation.
    Binder RK; Webb JG; Toggweiler S; Freeman M; Barbanti M; Willson AB; Alhassan D; Hague CJ; Wood DA; Leipsic J
    JACC Cardiovasc Interv; 2013 May; 6(5):462-8. PubMed ID: 23702010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of balloon expandable transcatheter valves for valve-in-valve implantation in patients with degenerative stentless aortic bioprostheses: Technical considerations and results.
    Bapat V; Davies W; Attia R; Hancock J; Bolter K; Young C; Redwood S; Thomas M
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):917-22; discussion 922-4. PubMed ID: 25037622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.